产品资料

AT3B-1细胞

如果您对该产品感兴趣的话,可以
产品名称: AT3B-1细胞
产品型号: AT3B-1
产品展商: HZbscience
产品文档: 无相关文档

简单介绍

AT3B-1细胞应如何避免细胞污染,细胞污染的种类可分成**、酵母菌、霉菌、病毒和霉浆菌。主要的污染原因为无菌操作技术不当、操作室环境不佳、污染之血清和污染之细胞等。严格之无菌操作技术、清洁的环境、与品质良好之细胞来源和培养基配制是减低污染之*好方法。AT3B-1细胞何时须更换培养基?视细胞生长密度而定,或遵照细胞株基本数据上之更换时间,按时更换培养基即可。


AT3B-1细胞  的详细介绍

AT3B-1细胞

器官来源: 前列腺

细胞形态: 上皮样

是否是肿瘤细胞: 0

物种来源: 褐鼠

年限: 22 months

运输方式: 冻存运输

数量: 大量

品系: Copenhagen

ATCC Number: CRL-2375™

AT3B-1细胞相关**: 其他**

Designations: AT3B-1

Depositors: KJ Pienta

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Organism: Rattus norvegicus deposited as rat

Morphology: epithelial


Source: Organ: prostate

Strain: Copenhagen

Disease: AT3B-1细胞malignant carcinoma

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Age: 22 months

Gender: male

Comments: AT3B-1 was derived from the AT-3 cell line. AT-3 was derived from a ***** malignant rat prostate tumor obtained from a 22 month old inbred Copenhagen rat by Isaacs et al. [39920]

The parental cells were grown in increasing concentrations of the drug doxorubicin until the final concentration of 0.001 mM was achieved.

These cells express a multidrug (MDR) resistant phenotype. They are more resistant to vinblastine compared to controls.

When P-glycoprotein was blocked, the AT3 B-1 cell line demonstrated drug efflux pump activity. Injection of AT3 B-1 cells into rats followed by doxorubicin treatment produced larger tumors compared to the parental controls. [39921]

AT3B-1细胞This cell line can be used to study chemotherapy resistance in prostate cancer.

Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 0.001 mM doxorubicin, 90%; fetal bovine serum, 10%

Temperature: 37.0°C

Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.

Add fresh culture medium, aspirate and dispense into new culture flasks.

Preservation: Culture medium, 95%; DMSO, 5%

Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

recommended serum:ATCC 30-2020

References: 39920: Isaacs JT, et al. AT3B-1细胞Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 9: 261-281, 1986. PubMed: 3774632

39921: Replogle-Schwab TS, et al. Development of doxorubicin resistant rat prostate cancer cell lines. Anticancer Res. 17: 4535-4538, 1997. PubMed: 9494564

沪公网安备 31011702004356号